KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Charles River Laboratories International (CRL) Current Leases (2018)

Charles River Laboratories International has reported Current Leases over the past 1 years, most recently at $3.2 million for Q4 2018.

Quarterly results put Current Leases at $3.2 million for Q4 2018, changed N/A from a year ago — trailing twelve months through Dec 2018 was $3.2 million (changed N/A YoY), and the annual figure for FY2018 was $3.2 million, changed.
Current Leases for Q4 2018 was $3.2 million at Charles River Laboratories International.
Over the last five years, Current Leases for CRL hit a ceiling of $3.2 million in Q4 2018 and a floor of $3.2 million in Q4 2018.